8.1.2021   
EN
Official Journal of the European Union
C 6/13
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 6 January 2021 to 6 January 2021

         

            
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
 
1

            
)

         

      
(2021/C 6/11)
—

                     
Issuing of a marketing authorisation
 (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): 
Accepted

                  
Date of the decision
Name of the medicinal product
INN (International Non-Proprietary Name)
Holder of the marketing authorisation
Number of the entry in the Community Register
Pharmaceutical form
ATC code (Anatomical Therapeutic Chemical Code)
Date of notification
6.1.2021
COVID-19 Vaccine Moderna
COVID-19 mRNA Vaccine (nucleoside modified)
MODERNA BIOTECH SPAIN, S.L. Calle Monte Esquinza 30, 28010 Madrid, España
EU/1/20/1507
dispersion for injection
J07BX
6.1.2021
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

                                 
European Medicines Agency

                              

                                 
Domenico Scarlattilaan 6

                              

                                 
1083 HS Amsterdam

                              

                                 
NETHERLANDS

                              

         
1
  
.
